ProfileGDS5678 / 1458083_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 59% 57% 57% 56% 55% 58% 57% 56% 55% 56% 57% 56% 57% 57% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.604859
GSM967853U87-EV human glioblastoma xenograft - Control 23.4349957
GSM967854U87-EV human glioblastoma xenograft - Control 33.4428457
GSM967855U87-EV human glioblastoma xenograft - Control 43.3501656
GSM967856U87-EV human glioblastoma xenograft - Control 53.3312455
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.6039358
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.5281357
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.410556
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.3569455
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.3818456
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.4281857
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.3752756
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4727957
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.4300957